Exam1BlueprintSpring21 mdc3 complete.docx - NUR 2502 MDC...

NUR 2502 MDC III – Examination Blue Print – Exam 1
* Disclaimer: this is meant to guide your studying and may not be comprehensive of what is on the exam . Anything in the
assigned book chapters is “fair game” to show up on the exam
Exam 1: 50 questions, 75 minutes- covers modules 1-3
Iggy Chapters:
Chapter 70
Chapter 71
Chapter 72
Chapter 73
Chapter 74
Chapter 65
Chapter 66
Chapter 67
Chapter 68
I recommend completing the following disorder templates to include for all: Patho, risk factors, assessment, diagnosis,
treatment, nursing considerations/patient education – additionally I will include below any additional topics beyond the
disorder template to focus on for individual disorders-
 Breast Cancer
Description
1. Breast cancer is classified as invasive when it penetrates the tissue surrounding the mammary duct and grows in an
irregular pattern.
2. Metastasis occurs via lymph nodes.
3. Common sites of metastasis are the bone and lungs; metastasis may also occur to the brain and liver.
4. Diagnosis is made by breast biopsy through a needle aspiration or by surgical removal of the tumor with microscopic
examination for malignant cells.
B. Risk factors
1. Age
2. Family history of breast cancer due to genetic predisposition
3. Early menarche and late menopause
4. Previous cancer of the breast, uterus, or ovaries
5. Nulliparity, late first birth
6. Obesity
7. High-dose radiation exposure to chest
C. Assessment
1. Mass felt during BSE (usually felt in the upper outer quadrant, beneath the nipple, or in axilla)
2. Presence of the lesion on mammography
3. A fixed, irregular nonencapsulated mass; typically painless except in the late stages
4. Asymmetry
5. Bloody or clear nipple discharge
6. Nipple retraction or elevation
7. Skin dimpling, retraction, or ulceration
8. Skin edema or peau d’orange skin
9. Axillary lymphadenopathy
10. Lymphedema of the affected arm
11. Symptoms of bone or lung metastasis in late stage
o
Self-screening and mammogram recommendations
Early detection: Regular BSE
1. 1. Performing BSE
1. a. Perform regularly 7 to 10 days after menses.
2. b. Postmenopausal clients or clients who have had a hysterectomy should perform BSE
regularly as well.
2. 2. Client instructions

1. E. Nonsurgical interventions
1. 1. Chemotherapy
2. 2. Radiation therapy
3. 3. Hormonal manipulation via the use of medication in postmenopausal women or other medications for
estrogen receptor–positive tumors
4. 4. Monoclonal antibodies such as trastuzumab for human epidermal growth factor receptor 2–positive (HER-2
+) breast cancer
2.
F. Surgical interventions: Surgical breast procedures, with possible breast reconstruction ( Box 44-12 )
3. G. Postoperative interventions
1. 1. Monitor vital signs.
2. 2. Position the client in a semi-Fowler’s position; turn from the back to the unaffected side, with the
affected arm elevated above the level of the heart to promote drainage and prevent lymphedema.